The FA Community Needs Your Help to Advance a Potential Treatment
Columns, My Darling Disability - a Column by Kendall Harvey
The Friedreich’s ataxia (FA) community has been abuzz with excitement recently. The first two phases of a clinical trial sponsored by Reata Pharmaceuticals showed that the oral therapy omaveloxolone ... Read more